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Herpes simplex virus type-1 (HSV-1) is a human pathogenic member of the Alphaherpesvirinae subfamily of
herpesviruses. The HSV-1 genome is a large double-stranded DNA specifying about 85 protein coding
genes. The latest surveys have demonstrated that the HSV-1 transcriptome is much more complex than it
had been thought before. Here, we provide a long-read sequencing dataset, which was generated by using
the RSII and Sequel systems from Paciﬁc Biosciences (PacBio), as well as MinION sequencing system from
Oxford Nanopore Technologies (ONT). This dataset contains 39,096 reads of inserts (ROIs) mapped to the
HSV-1 genome (X14112) in RSII sequencing, while Sequel sequencing yielded 77,851 ROIs. The MinION
cDNA sequencing altogether resulted in 158,653 reads, while the direct RNA-seq produced 16,516 reads.
This dataset can be utilized for the identiﬁcation of novel HSV RNAs and transcripts isoforms, as well as for
the comparison of the quality and length of the sequencing reads derived from the currently available long-
read sequencing platforms. The various library preparation approaches can also be compared with
each other.
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Background & Summary
Herpes simplex virus type-1 (HSV-1) is a human pathogenic herpesvirus belonging to the family of
Herpesviridae. HSV-1 is associated with orofacial infections1. This is a highly contagious and lifelong
infection that is widespread in the world2. HSV-1 is a prototype herpesvirus, which is used as a model
organism in the study of molecular pathogenesis of the lytic and latent viral infection, and it is also used
as a gene delivery vector3,4 for basic research and gene therapy5, as well as in oncolytic virotherapy6.
HSV-1 has a large (~152 kbp) double-stranded DNA genome and a very complex transcriptome7.
Here, we provide a large RNA-seq dataset derived from third- and fourth-generation8 long-read
sequencing (LRS) methods (Fig. 1). The previously applied short-read sequencing approaches are
inefﬁcient in distinguishing between embedded gene products, RNA isoforms and overlapping
transcripts. This problem can be circumvented by LRS methods that are capable of identifying full-length
transcripts9–13. Our major aim with this study was to provide a dataset that can be suitable for deeply
characterizing the complexity of the HSV-1 transcriptome proﬁle and for obtaining a detailed picture on
the transcript-level variations. In order to achieve this goal, the currently available LRS techniques, the
Paciﬁc Biosciences (PacBio) and the Oxford Nanopore Technologies (ONT) platforms were used for the
characterisation of the HSV-1 lytic transcriptome. We used the RSII7 and the Sequel isoform sequencing
(Iso-Seq) approaches for the analyses of both the polyadenylated fraction and the total transcriptome of
the HSV-1 transcripts. The ampliﬁed Iso-Seq method was used for cDNA sequencing. We used the ONT
MinION technique for both cDNA and direct (d)RNA sequencing for the investigations of the poly(A)
RNA molecules.
The utilized sequencing methods along with the various library preparation approaches were as
follows, PacBio: oligo(d)T-primed and random-hexamer primed Iso-Seq protocol with or without size-
selection, as well as ONT: cDNA-sequencing, cDNA-sequencing using 50 Cap-selected transcripts, and
dRNA sequencing. These techniques allow for the detection of novel transcript isoforms (splice and
length variants), as well as several novel protein-coding RNAs, non-coding (nc)RNAs, and polycistronic
transcripts. This LRS dataset is also useful for the investigation of the transcriptional overlaps.
Additionally, these data can be used to compare the “sequencing by synthesis” method with the
nanopore-based approach. The various library preparation approaches can also be compared with
each other.
We used 17 SMRT Cells for the sequencing of our samples on RSII system, using the P6-C4 chemistry.
The movie time was 240 or 360 per SMRT Cell. Samples were also run on a single Sequel SMRT Cell
using P6-C4 chemistry with 600 min movie time. Altogether 7 MinION ﬂow cells were applied for
sequencing the different ONT libraries. The raw reads were aligned to the HSV-1 reference genome in
each case (X14112).
The PacBio RSII sequencing generated 38,601 reads of inserts (ROIs) using oligo(d)T-primed reverse
transcription (RT), while, using the Sequel platform, we obtained 77,851 HSV-1 speciﬁc ROIs. Overall,
the different ONT methods generated 175,169 viral reads (Table 1). The average read lengths are as
follows: 1,536 and 1,000 bp for the no size-selected oligo(d)T-primed and random-primed RSII,
respectively; 2,104 for the Sequel, while the obtained read lengths are 1,466, 1,067 and 1,111 bp for the
MinION cDNA, Cap-selected cDNA, and direct RNA-seq methods (Table 2, Fig. 2).
The dataset generated here is expected to provide valuable information for the herpesvirus studies and
will open new possibilities for the investigation of HSV-1 at the molecular level. Our data provides a
wide-ranging resource for understanding, comparing, and analysing the utilized library preparation and
sequencing methods, as well as this valuable data can be used to design novel bioinformatics pipelines
and also to test the currently available ones.
Figure 1. Data ﬂow diagram shows the detailed overview of this research.
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Here, we provide a comprehensive overview about preparation methods of sequencing libraries, as
well as a description of the data (Figure 1, Table 3). Detailed statistics about the read quality, such as
insertions, deletions, and mismatches, as well as the coverages of the pre-processed data (binary
alignment (BAM)) can be found in Table 4 and Fig. 3. The data show that the ONT MinION sequencing
resulted in relatively high error rates for insertions, deletions and mismatches. The best read quality (i.e.
less insertions, deletions and mismatch) – as expected – was obtained from the PacBio runs. The
composition of the errors of the three sequencers (RSII, Sequel, MinION) are different. Mismatches are
the most common errors in ONT, while the insertions are the least frequent errors in ONT (consistent
with the previously published data14). Intriguingly, contrary to others’ datasets14, deletions are the major
errors in our RSII data; the Sequel shows the same pattern as was expected14. The read length distribution
of the samples is visualized in Fig. 4 and Fig. 5 Porechop tool (https://github.com/rrwick/Porechop) was
used to carry out an analysis on the 50 and 30 adapters, with which we were able to determine the
orientation of the sequencing reads (Table 5 (available online only), Table 6, Fig. 6). About 90% of the
PacBio reads could be categorized as forward or reverse oriented read, but only 66%, 58% and 49% from
the 1D-seq, Cap-seq and random libraries could be categorized, respectively.
The ratio of the complete (full-length) reads in the different samples were also calculated (Fig. 7). The
data shows that the random-primed cDNA sequencing as well as the dRNA sequencing resulted in very
few complete reads, which has a technical reason: random primed sequencing could gain complete reads
when the random primer binds to the 30-end of the RNA. The small number of full-length reads, from the
dRNA sequencing is consistent with our previous ﬁndings: we observed that the dRNA sequencing
resulted in poor 5′ and 3′ read ends15,16. It can also be seen that nanopore sequencing produces a large
number of incomplete reads; these short fragments are probably removed from PacBio sequencing by the
MagBead loading.
Sample Mapped read count
RSII PolyA size selected: 0.8–2 kb 5689
RSII PolyA size selected: 2–3 kb 3669
RSII PolyA size selected: 3–5 kb 12431
RSII PolyA size selected: 5 kb+ 7010
RSII PolyA non size selected 10796
RSII random-primed 516
Sequel 78362
MinION PolyA and Cap selected
cDNA seq
36386
MInION PolyA cDNA seq 67475
MinION random-primed cDNA seq 60687
MInION direct RNA seq 16997
Table 1. Summary of the obtained read counts aligned to the HSV-1 reference genome.
Sample Median read
lengths
Average read lengths
± SD
Median aligned read
lengths
Average aligned read
lengths± SD
RSII PolyA size selected: 0.8-2kb 1374 1385 ± 341,29 1286 1283 ± 316,64
RSII PolyA size selected: 2-3kb 1442 1543 ± 538,90 1346 1442 ± 503,44
RSII PolyA size selected: 3-5kb 1355 1333 ± 503,22 1241 1216 ± 462,89
RSII PolyA size selected: 5kb+ 1724 1815 ± 794,21 1605 1588 ± 739,83
RSII PolyA non size selected 1434 1536 ± 607,55 1338 1372 ± 488,48
RSII random-primed 903 1000 ± 459,25 830 925 ± 461,45
Sequel 1823 2104 ± 814,41 1723 1952 ± 768,24
MinION PolyA and Cap selected cDNA seq 999 1067 ± 598,68 620 709 ± 355,75
MInION PolyA cDNA seq 1313 1466 ± 844,69 1000 1046 ± 679,91
MinION random-primed cDNA seq 801 910 ± 521,04 717 822 ± 491,69
MInION direct RNA seq 1041 1111 ± 673,45 904 948 ± 565,86
Table 2. Summary table of the obtained read lengths from PacBio RSII and Sequel, as well as from
ONT MinION sequencing.
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Methods
A part of the methods section (PacBio RSII sequencing) is an expanded version of descriptions in our
related work7, however, the largest part of the data including the entire PacBio Sequel and ONT
sequencing data has not yet been published elsewhere.
The various library preparation and sequencing methods utilized in this study are shown in Figure 1.
Viruses, cells and infection
The Vero immortalized kidney epithelial cell line, derived from the kidney of an African green monkey
(Cercopithecus aethiops) was used for maintaining and propagating HSV-1. The cell culture was grown in
Dulbecco’s modiﬁed Eagle medium (DMEM, Gibco/Thermo Fisher Scientiﬁc) with 10% Foetal Bovine
Serum (Gibco/Thermo Fisher Scientiﬁc) and 100 μl/ml Penicillin-Streptomycin 10 K/10 K Mixture
Figure 2. The average read lengths in the various library preparation and sequencing methods. Error bars
represents the standard deviance (SD).
Sample No Sample Sample time points (h pi) RT priming Cap-selection Ampliﬁcation Size selection Library prep Platform
1 Mixed 1, 2, 4, 6, 8, 12 Oligo(d)T no yes Bluepippin 0.8-2kb PacBio Isoform seq RSII
2 Mixed 1, 2, 4, 6, 8, 12 Oligo(d)T no yes Bluepippin 2-3kb PacBio Isoform seq RSII
3 Mixed 1, 2, 4, 6, 8, 12 Oligo(d)T no yes Bluepippin 3-5kb PacBio Isoform seq RSII
4 Mixed 1, 2, 4, 6, 8, 12 Oligo(d)T no yes Bluepippin 5kb+ PacBio Isoform seq RSII
5 Mixed 1, 2, 4, 6, 8, 12 Oligo(d)T no yes no PacBio Isoform seq RSII
6 Mixed 1, 2, 4, 6, 8, 12 Random no yes no PacBio Isoform seq RSII
7 Mixed 1, 2, 3, 4, 5, 6, 8, 12, 18, 24 Oligo(d)T no yes no PacBio Isoform seq Sequel
8 Mixed 1, 2, 3, 4, 5, 6, 8, 12, 18, 24 Oligo(d)T yes yes no ONT cDNA MinION
9 Mixed 1, 2, 3, 4, 5, 6, 8, 12, 18, 24 Oligo(d)T no yes no ONT cDNA MinION
10 Mixed 1, 2, 3, 4, 5, 6, 8, 12, 18, 24 Random no yes no ONT cDNA MinION
11 Mixed 1, 2, 3, 4, 5, 6, 8, 12, 18, 24 Oligo(d)T no no no ONT Direct RNA MinION
Table 3. Summary table of the various wet lab methods utilized in this project.
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(Lonza), and in a 37 °C incubator with a humidiﬁed atmosphere of 5% CO2 in air. The viral stocks were
prepared by infecting rapidly-growing semi-conﬂuent cells with viruses at a multiplicity of infection
(MOI) of 1 plaque-forming unit (pfu)/cell. The infected cells were incubated until complete cytopathic
effect was observed. Three times freeze-thaw cycles were applied and it was followed by a centrifugation
step at 10,000 ´ g for 15 min. Cells were infected in a suspension with HSV-1 at an MOI of 1, then they
were incubated for 1 h. The virus suspension was removed and cells were washed with phosphate-
buffered saline (PBS). This step was followed by the addition of fresh medium to the cells and they were
incubated for 1, 2, 4, 6, 8, or 12 h for the RSII sequencing and for 1, 2, 3, 4, 5, 6, 8, 12, 18, or 24 h for the
Sequel and MinION runs.
RNA puriﬁcation
Total RNA extraction. Total RNA isolation was carried out by using the NucleoSpin® RNA kit
(Macherey-Nagel) following the kit’s recommendations and our previously published methods12. In sum,
the viral infected cells were lysed in a lysis puffer (containing chaotropic ions which inhibit ribonucleases,
supplied by the kit). DNase I (provided by the kit) treatment was carried out during the puriﬁcation. The
RNA samples, which were bound to a silica membrane, were eluted in RNase-free water. The potential
residual DNA contamination was eliminated by applying additional DNase treatment; the Ambion®
TURBO DNA-freeTM Kit was used (Thermo Fisher Scientiﬁc). The ﬁnal concentrations of the RNA
samples were measured by Qubit® 2.0 Fluorometer using Qubit RNA BR Assay Kit (Life Technologies)
and then they were stored at −80 °C until further use. The RNA samples taken from each time points
were mixed for library preparation and sequencing.
Ribosomal RNA depletion. For the random hexamer-primed cDNA sequencing, the RNA samples
were handled with the ribodepletion kit (Epicentre Ribo-ZeroTM Magnetic Kit H/M/R, Epicentre/
Illumina), to remove the ribosomal (r)RNAs.
Isolation of polyadenylated RNA. For the sequencing of the polyadenylated [polyA(+)] fraction of the
samples, RNAs were puriﬁed by using the Qiagen Oligotex mRNA Mini Kit, following to the “Spin
Columns” protocol of the kit.
The ﬁnal concentrations of the rRNA depleted and the PolyA(+) RNA samples were determined
through use of the Qubit RNA HS Assay Kit (Life Technologies).
Preparation of cDNAs and sequencing libraries
PacBio SMRTbell library preparation. Full-length cDNAs were prepared according to the PacBio
Isoform Sequencing (Iso-Seq) protocol by using the Clontech SMARTer PCR cDNA Synthesis Kit. We
applied the no Size Selection protocol for the study of short RNAs, while we carried out size selection by
using SageELFTM and BluePippinTM Size-Selection Systems (Sage Science) for the isolation of long
transcripts. Reverse transcription (RT) reactions were primed with oligo(d)T (supplied by the Clontech
Kit) or random hexamer primer (custom designed, ordered from IDT DNA). Samples were ampliﬁed by
PCR using KAPA HiFi Enzyme (Kapa Biosystems), according to the above mentioned PacBio protocol.
In short, primary denaturation was done at 95 °C for 2 min. This step was followed by 16 cycles for PA-
sequencing, as well as 20 or 30 cycles for random hexamer-primed samples (the optimal cycle was
determined in the optimization step) at 98 °C for 20 s (denaturation), 65 °C for 15 s (annealing) 72 °C for
4 min (extension). 72 °C was used for the ﬁnal extension, it was set to 5 min. (n: 18 cycles was set to the
No size-selection protocol, and the same PCR setting was applied for size-selected samples.
Sample Percentage of deletions
(%) ± SD
Percentage of insertions
(%) ± SD
Percentage of mismatches
(%) ± SD
Coverage
RSII PolyA size selected: 0.8-2kb 0,84 ± 1,25 0,35 ± 0,88 0,76 ± 0,49 47.70
RSII PolyA size selected: 2-3kb 0,79 ± 1,22 0,41 ± 0,91 0,74 ± 0,46 34.40
RSII PolyA size selected: 3-5kb 0,75 ± 1,25 0,38 ± 1,01 0,77 ± 0,56 98.24
RSII PolyA size selected: 5kb+ 0,87 ± 1,67 0,94 ± 3,43 1,52 ± 3,19 66.93
RSII PolyA non size selected 0,90 ± 1,27 0,61 ± 1,18 0,72 ± 0,50 95.43
RSII random-primed 0,92 ± 1,68 0,23 ± 0,78 0,71 ± 0,49 3.01
Sequel 0,41 ± 0,64 1,18 ± 2,53 0,78 ± 0,61 998.24
MinION PolyA and Cap selected cDNA seq 7,43 ± 2,08 3,09 ± 2,15 8,81 ± 2,44 161.48
MInION PolyA cDNA seq 7,74 ± 2,06 3,61 ± 2,17 8,75 ± 2,47 444.16
MinION random-primed cDNA seq 5,41 ± 2,40 3,75 ± 2,24 6,63 ± 2,23 320.17
MInION direct RNA seq 9,76 ± 2,24 2,72 ± 2,12 8,36 ± 1,98 102.81
Table 4. Summary of the read qualities gained from the utilized long-read sequencing approaches.
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Figure 3. Summary of the read qualities gained from the utilized long-read sequencing approaches.
(a) Percentage of deletions; error bar represents the SD values. (b) Percentage of insertions with SD values.
(c) Percentage of mismatches given together with SD values. (d) Average read coverages across the
HSV-1 genome.
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Figure 4. Read length distributions. (a) The average distribution of read lengths which align to the HSV-1
genome; binned to 500 bp intervals. *Percentage values are in Figure 3. (b) The divided bar chart shows
the number of reads at log10 scale, binned to 100 bp intervals. The samples can be seen broken down according
to the library preparation and/or sequencing approaches in C–E. (c) Read lengths distributions at log10 scale,
binned to 1,000 bp ranges. This ﬁgure shows the RSII size-selected samples. It can be seen that the majority
www.nature.com/sdata/
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PCR products were mixed together and then size selected with the SageELFTM System following the
PacBio’s protocol. Size-selected cDNAs were ampliﬁed with KAPA enzyme using the above mentioned
conditions. The cDNAs with a size over 5 kb was size-selected again, with the BluePippinTM System to
remove the short samples. Five-hundred ng of each non-size-selected sample was used for the generation
of the SMRTbell templates, with the PacBio DNA Template Prep Kit 1.0. The quantity of the size-selected
cDNAs used in the SMRTbell template preparation reaction was based on the following protocols:
Procedure & Checklist – Isoform Sequencing (Iso-SeqTM) using the Clontech SMARTer PCR cDNA
Synthesis Kit and SageELFTM Size Selection System & BluePippinTM Size-Selection Systems. The DNA/
Polymerase Binding Kit P6 and v2 primers were used to generate SMRTbell library-DNA polymerase
complexes. The ready complexes were bound to MagBeads using the PacBio MagBead Binding Kit.
The volume of the sequencing primer for the annealing, and the polymerase (P5 or P6) for the binding
was determined using the PacBio Calculator version 2.3.1.1. by adding the concentrations and the average
insert sizes of SMRTbell templates.
The polymerase-template complexes were bound to MagBeads, loaded onto SMRT Cells and
sequenced on the RSII instrument.
of the reads mapped to the HSV-1 genome are shorter than 3,000 bps, most of the reads are between
1,001–2,000 bps, independently from the focus of the size selection. (d) This bar chart shows that the same library
preparation method (Isoform sequencing with no size selection using Clontech SMARTer PCR cDNA Synthesis
Kit) result in different read length distribution using the two PacBio platforms: 40% of the Sequel reads are longer
than 2,000 bp, while only 10% of the RSII reads belong to this size range. (e) The average read length using the
MinION nanopore sequencing is below 2,000 bp. There is no random primed read above 9,000 bp. Intriguingly,
the longest reads are derived from the direct RNA sequencing approach (15,000–19,000 bp).
Figure 5. Percentage values of number of read counts binned to 500 bp. This heat map-like illustration
shows the distribution of read counts within 500 bp intervals. This dataset shows that the Sequel sequencer
resulted in longer average read lengths (~79% of the reads are longer than 1,500 bp). The size selection of the
RSII samples had a signiﬁcant effect on the average read lengths: even if most of the reads are within 1,000–
2,000 bp, the distribution of the read counts is different: 0.8–2 kb: 87,560%; 2–3 kb: 73,493%; 3–5 kb: 73,543%;
>5 kb: 69,487% of the reads are within this range. The MinION sequencing on the poly(A)-selected samples
shows about the same read length distribution as the non-size-selected RSII (the majority of the reads is within
the 1,000–2,000 bp interval, however, the distribution of the MinION reads is smoother. The Cap-selected
samples and the direct RNA samples have a peak at the lower range: about 30–35% of the reads are between
501–1,000 and 1,001–1,500 bp in both samples. The random primed samples (RSII and MinION) generated
the shortest average read lengths.
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Figure 6. Comparing the Porechop results derived from the analysis of different libraries. (a) This ﬁgure
shows the percentages of read counts derived from different PacBio RSII poly(A) sequencing. (b) This bar chart
compares the data derived from the two PacBio approaches. We could detect the adapters on more than 90%
Sequel reads, while we obtained in a poorer result from RSII. (c) This diagram compares the ONT’s own library
preparation approach (1D) with the Lexogen Teloprime Cap-selection protocol, which used for a library, run
on a MinION ﬂow cell. (d) We were not able to identify the orientation of about 50% of reads using the
random-primed approach, while dRNA-seq could detect adapters on about 20% of the reads. (e) Segmented pie
chart illustrates the distribution of reads with (labelled as: Fw and Rev) or without orientation (labelled as: No
orientation). Fifty-six % of this dataset derived from the different nanopore sequencing approaches, 26.5%
from Sequel and the remaining less than 20% is from the RSII. A high ratio (~90%) of reads from PacBio RSII
and Sequel sequencing could be categorized as Fw or Rev, however Porechop were not able to identify the
adapters and thus the orientation of at least about 30% of reads.
Figure 7. Bar chart represents the full-length and partial read distributions in the different libraries.
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The Binding Calculator (PacBio) was used to calculate the amount of samples to be used for
sequencing, following MagBead one-cell per well (OCPW) method. The P6v2 binding kit was used, the
on-plate concentration was set to 0.05 nM. The insert sizes were set based on the applied size-selections:
1000, 2500 and 6000 bp sizes were chosen.
Brieﬂy, the sequencing primer was diluted in PacBio Elution Buffer (EB) to 150 nM. The annealing step
was carried out using 1 μl template (cc: ~20 ng/μl), the diluted sequencing primer and primer buffer
(10×). The concentration of this reaction mixture was 0.8333 nM. Annealing step was set to 20 °C for 30
min. The DNA polymerase enzyme was diluted to a ﬁnal concentration of 50 nM in PacBio Binding
Buffer (BB) v2, and then it was bound to the annealed sample followed by the addition of DTT, dNTP
and BB. The sample complex (ﬁnal concentration was set to 0.5 nM) was incubated at 30 °C for 4 h. The
complex (0.5 μl) was added to 18.5 μl MagBead BB (ﬁnal concentration was set to 0.0125 nM). The
detailed protocol of the MagBeads preparation is as follows: 73.9 μl MagBeads were washed with
MagBead Wash Buffer, then it was replaced by MagBead BB (73.9 μl). The washed MagBead was used to
bound to the sample-complex. Nineteen μl from the complex was added to the washed MagBeads and
then they were incubated in a HulaMixer (Life Technologies) at 4 °C for 30 min. After this binding step,
the sample was puriﬁed with BB (19 μl), then with 19 μl WB. The ﬁnal elution was in 19 μl BB. The
MagBead-bound sample complexes were loaded for sequencing.
The MagBead One Cell Per Well protocol was applied for the sequencing. Sequencing runs were
performed by using the PacBio RS II sequencer or Sequel platform. Size-selected and no size-selected
samples were run on RSII, while the Sequel platform was applied for the no size-selected samples. The
DNA Sequencing Reagent 4.0 was used for the reactions. Two hundred and forty min or 360 min movie
lengths were set for the RSII runs, while 600 min was applied for the Sequel sequencing (one movie was
recorded for each SMRT Cell).
Direct RNA sequencing
To avoid the potential false-priming effect of PCR reactions, an ampliﬁcation free method was used for
the analysis of HSV-1 transcripts. For this, the ONT’s Direct RNA sequencing (DRS) protocol (Version:
DRS_9026_v1_revM_15Dec2016) was utilized. A total RNA sample containing an equal amount from
the 10 time points (1, 2, 3, 4, 5, 6, 8, 12, 18, 24 h pi) was used to isolate the polyadenylated RNA fraction.
This sample (115 ng) was then used as template for the RT, it was added to the RT adapter (supplied by
the DRS kit) (Table 7). T4 DNA ligase (2 M U/ml; New England BioLabs) was also added to the reaction.
The reaction mixture was incubated at room temperature for 10 min. SuperScript (SS)III RT enzyme (Life
Technologies) was added to the RNA-cDNA hybrid, and the generation of the ﬁrst-strand cDNA was
carried out according to the ONT DRS kit’s recommendations: the reaction was done at 50 °C for 50 min,
then the SSIII was inactivated at 70 °C (10 min). The RNase OUT (40 U/μl; Life Technologies)
recombinant RNase inhibitor–treated Agencourt AMPure XP Magnetic Beads (Beckman Coulter) was
used to purify the sample (2U RNase OUT per 1 μl bead), then it was eluted in 20 μl Nuclease-Free Water
(Ambion/Thermo Fisher Scientiﬁc). T4 DNA ligase and NEBNext Quick Ligation Reaction Buffer (New
England BiceoLabs) were used to ligate the puriﬁed sample to the RMX adapter. The ligation was done at
room temperature. The incubation time was 10 min. The adapter-ligated sample was puriﬁed with the
RNase OUT-handled XP beads using Wash Buffer (DRS Kit), and then eluted in 21 μl Elution Buffer
(DRS Kit). The quantiﬁcation of the ready libraries was performed using the Qubit 2.0 Fluorometer as
well as Qubit dsDNA HS Assay Kit (both from Life Technologies). The R9.4 SpotON Flow Cell was used
for MinION sequencing.
Oxford Nanopore 1D cDNA sequencing
Samples were sequenced on a MinION device from the ONT according to the ONT 1D Strand switching
cDNA by ligation protocol (Version: SSE_9011_v108_revS_18Oct2016). The sequencing libraries were
START END
MinION cDNA TTACGGCCGGG CCCGGCCGTAA
CAP 5’ CTCACTATAG CTATAGTGAGT
CAP 3’ TCTCAGGCG CGCCTGAGA
CAP 3’ PolyA TCTCAGGCGTTTTTTTTTTTTTTTTTT AAAAAAAAAAAAAAAAAACGCCTGAGA
PolyA TTTTTTTTTTTTTTTTTTTT AAAAAAAAAAAAAAAAAAAA
PacBio AGAGTACATGGG CCCATGTACTCT
PCR tail 1 TTAACCTTTCTGTTGGTGCTGATATTGC GCAATATCAGCACCAACAGAAAGGTTAA
PCR tail 2 TTAACCTACTTGCCTGTCGCTCTATCTTC GAAGATAGAGCGACAGGCAAGTAGGTTAA
Table 6. This table shows the adapter sequences of the various library-preparation methods, which
were used to determine the orientation of transcripts.
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generated by using the ONT Ligation Sequencing Kit 1D (SQK-LSK108). The PolyA(+)-selected RNA
fraction or the rRNA-depleted sample was used for cDNA production. Identical quantity of RNA samples
from each of the applied time points were mixed together.
Thirty-one ng from the Poly(A+)-selected, or 50 ng from the rRNA-depleted sample was used as
template for the RT reactions. An anchored oligo(d)T primer [(VN)T20; ordered from Bio Basic, Canada,
(Table 7)] or a modiﬁed random-primer (Table 7) was used for priming the reactions. The RNA-primer
mixture was incubated at 65 °C for 5 min. After this short step, a strand-switching oligo [containing three
O-methyl-guanine RNA bases (PCR_Sw_mod_3G; Bio Basic, Canada)], buffer and DTT [both are
derived from the SuperScript IV Reverse Transcriptase kit (Life Technologies)] were added to the
reactions. The samples were handled with a recombinant RNase inhibitor (RNase OUTTM, Life
Technologies); the incubation was carried out at 42 °C 2 min.
The SuperScript IV Reverse Transcriptase enzyme (200 unit) was added to the sample. The RT
reaction was carried out in a Veriti Cycler (Applied Biosystems) at 50 °C for 10 min. It was followed by
the strand-switching step at 42 °C for 10 min. Samples were heated to 80 °C (10 min) to inactivate the
enzymes. Samples were ampliﬁed by PCR with KAPA HiFi DNA Polymerase (Kapa Biosystems)
and Ligation Sequencing Kit Primer Mix (1D Kit). Five μl from the cDNAs were used as template in each
of the PCR reactions. The Veriti PCR machine was set as follows: initial denaturation 95 °C, 30 sec (1
cycle); denaturation 95 °C, 15 sec (15 cycles); annealing 62 °C 15 sec (15 cycles); extension 65 °C 4 min
(15 cycles); ﬁnal extension step 65 °C, 10 min. NEBNext End repair/dA-tailing Module (New England
Biolabs) was utilized for repairing the DNA ends, while the NEB Blunt/TA Ligase Master Mix
(New England Biolabs) was used for ligating the adapters (1D kit). The Beckman Coulter Agencourt
AMPure XP beads were used to purify the DNA after each of the enzymatic steps. The concentration of
the samples was measured by using the Qubit Fluorometer 2.0 (Life Technologies) and the Qubit (ds)
DNA HS Assay Kit (Life Technologies). The libraries were sequenced on the ONT R9.4 SpotON
Flow Cells.
MinION cDNA sequencing on Cap-selected samples
To generate full-length cDNA from capped and polyadenylated RNAs, the “all-in-one” protocol from the
Lexogen was applied using the TeloPrime Full-Length cDNA Ampliﬁcation Kit. A 2.2 μg mixture from
the different total RNAs (1, 2, 3, 4, 5, 6, 8, 12, 18 and 24 h pi) was used for the RT. For this, the sample
was mixed with RT buffer and a speciﬁc primer (both are the part of the kit, Table 7). The reaction started
at a 30 sec incubation at 70 °C, then it was followed by a 1 min step at 37 °C. At this point, the reaction
was kept at 37 °C. The reverse transcriptase and the additional reagents (derived from the kit) were mixed
with the sample and then the incubation was containing at 37 °C for 2 min. The next step of the RT
reaction was carried out at 46 °C for 50 min. Sample was puriﬁed by using the kit’s Silica columns. The
double-strand (ds) speciﬁc ligase enzyme (Lexogen kit) was used to join the adapter to the cDNA, the
reaction was performed at 25 °C, overnight, then the sample was puriﬁed using the silica membranes of
the Lexogen kit. The dscDNAs were generated by using the Enzyme Mix and the Second-Strand Mix
(Lexogen kit). The cDNA production was performed in a Veriti cycler. The following protocol was
applied: 98 °C for 90 sec, 62 °C for 60 sec, 72 °C for 5 min (16 cycles), hold at 25 °C. The sample
Sequencing method Name, availability Catalog # Sequence (50 -> 30)
PacBio ampliﬁed PolyA 3' SMART CDS primer II A - SMARTer PCR cDNA
Synthesis Kit (Clontech)
634925 & 634926 AAGCAGTGGTATCAACGCAGAGTAC(T)30VN
PacBio ampliﬁed Random Custome made (IDT DNA) --- AAGCAGTGGTATCAACGCAGAGTACNNNNNN (G: 37%; C: 37%; A: 13%; T: 13%)
MinION CAP selected TeloPrime Full-Length cDNA Ampliﬁcation Kit (Lexogen) 013.08 & 013.24 TCTCAGGCGTTTTTTTTTTTTTTTTTT
MinION cDNA Poly(T)-containing anchored primer [(VN)T20 - ONT recommended,
custom made (Bio Basic)
--- 5phos/ACTTGCCTGTCGCTCTATCTTC(T)20VN
MinION Random Custome made (IDT DNA) --- 5Phos/ACTTGCCTGTCGCTCTATCTTCNNNNNN
MinION RNA RT adapter - Direct RNA Sequencing Kit (Oxford Nanopore Technologies) SQK-RNA001 GAGGCGAGCGGTCAATTTTCCTAAGAGCAAGAAGAAGCCTTTTTTTTTT
Table 7. The list of reverse transcription primers used in this study.
Primer Sequence
Forward GGCTGCTCCGCTAAAAGAC
Reverse AGTTAAAGGCTGGGTGCAAA
Table 8. The sequence of the primer-pair used for the detection of us9 gene of HSV-1 by qPCR.
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concentration was detected by using Qubit 2.0 and Qubit dsDNA HS quantitation assay (Life
Technologies). The speciﬁcity of the obtained product was checked by using real-time PCR. The Rotor-
Gene Q qPCR machine (Qiagen), a gene speciﬁc primer (us9, 10 μM each, ordered from IDT DNA,
Table 8), and the ABsolute qPCR SYBR Green Mix (Thermo Fisher Scientiﬁc) was applied. The
preliminary denaturation was carried out at 94 °C for 15 min, then 35 cycles of 94 °C for 25 sec, 60 °C 25
sec and 72 °C 6 sec was applied.
The cDNAs from polyadenylated-capped RNA samples were used for library preparation for ONT
sequencing. The 1D Strand switching cDNA by ligation method was used. After the end-repair, the
samples were ligated to the 1D adapters. Finally, they were measured on the ONT R9.4 SpotON
Flow Cells.
Read processing
The SMRT Analysis v2.3.0 (PacBio RSII), the SMRT Link (PacBio Sequel) and the Albacore v2.0.1 (ONT
MinION) software packages were used for base calling (Figure 1). The reads were mapped by using
GMAP and the following setting was applied: Minimum Full Passes = 1, Minimum Predicted
Accuracy = 90, Minimum Length of Reads of Insert = 1, Maximum Length of Reads of Insert = No
Limit. These consensus reads were mapped using GMAP17, with the following settings: gmap -d
Genome.fa --nofails -f samse File.fastq>Mapped_ﬁle.sam. The quality information was acquired by
using custom made routines18.
The Porechop v.0.2.3 software was used to determine the orientation of the sequencing reads. For this,
a modiﬁed adapter.py ﬁle was used, where we added the various, library-speciﬁc adapter sequences
(Table 6). The ﬁrst mapped nucleotide downstream the “END” adapter was labelled the 50 end of a read,
while the last mapping nucleotide upstream of the “START” (polyA tail: A20 or 30 adapters) was
designated the 30 end of the read. Reads lacking an adapter on both ends, or with 50 or 30 adapters on both
ends, can be discarded from further in silico analysis.
Code Availability
1. SMRT Analysis v2.3.0: https://s3.amazonaws.com/ﬁles.pacb.com/software/smrtanalysis/2.3.0/smrta
nalysis-patch_2.3.0.140936.p5.run
2. SMRT Link v5.1.0: https://downloads.pacbcloud.com/public/software/installers/smrtlink_5.1.0.
26412.zip
3. Albacore v2.0.1: https://github.com/Albacore/albacore
4. GMAP: http://research-pub.gene.com/gmap/ (version 2015-12-31)
5. Custom routines have been archived on Github (https://doi.org/10.5281/zenodo.1034511).
6. Porechop v.0.2.3: https://github.com/rrwick/Porechop
Data Records
Data from MinION and Sequel sequencing have been uploaded to the European Nucleotide Archive
(Data Citation 1) - contains BAM ﬁles. The RSII raw sequencing ﬁles, processed data ﬁles as well as
metadata have been submitted to the Gene Expression Omnibus repository (Data Citation 2). All reads
were mapped to the X14112 genome build. The provided sequencing data can be used without
restrictions.
Technical Validation
The quantity of the puriﬁed total RNAs, the polyA-selected RNAs, the ribodepleted RNA samples, as well
as the cDNA samples and the ﬁnal sequencing libraries were detected by Qubit 2.0 (Life Technologies)
ﬂuorometer using the Qubit RNA Broad-Range, High Sensitivity RNA and High Sensitivity dsDNA
Assay Kits.
Usage Notes
Our provided dataset was primarily generated to analyse the potential splice variants, as well
as transcriptional start and stop site variations, the isoforms and the complexity of HSV-1 transcriptome.
The provided raw RSII data ﬁles can be utilized to develop novel base calling algorithms or
read processing tools, as well as to improve the currently existing bioinformatics software. The
uploaded BAM ﬁles contain reads already aligned to the X14112 HSV-1 reference genome using GMAP
v2017-04-2417.
These mapped reads can be further analysed by using different long-read aligners (e.g. NGMLR:
https://github.com/philres/ngmlr; GraphMap: https://github.com/isovic/graphmap, etc.), or bioinfor-
matics tools (e.g. samtools19 and bedtools20). These data can be visualized by utilizing different programs
such as the Geneious21, IGV22, or Artemis23. The ﬁles contain terminal poly(A) sequences as well as the
50and 30 adapter sequences, which can be utilized to determine the orientations of the reads. Novel long-
read sequencing pipelines e.g.: SQANTI24 can be tested using this dataset.
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